NOVALIX
HQ - Strasbourg
Summary
NovAliX is a drug discovery CRO supporting therapeutic programs from target identification to preclinical candidates using advanced chemistry, pharmacology, and biophysical techniques.
Deals Overview
Total Deals1
Valued Deals0
Total Value-
Avg. Deal Size-
Senior Management
Denis Zeyer
CEO
Christophe Dubost
CFO
Stephan Jenn
Co-Founder
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite